Protein discovery reveals potential treatment target for common fatty liver disease



The mechanisms that cause the world’s most common chronic liver disease—metabolic dysfunction-associated steatotic liver disease (MASLD)—to develop and progress are still not fully understood.

Leave a Reply

Your email address will not be published. Required fields are marked *

Prove your humanity: 2   +   1   =